In this study, we aimed to assess the cancer risk among patients with periodontal disease. Patients diagnosed with periodontal diseases at Hacettepe University between 2007 and 2012 were included and data on the diagnosis of any cancer after periodontal disease were collected from patient files. The age- and sex-standardized incidence rates (SIRs) were calculated using Turkish National Cancer Registry 2013 data. A total of 5199 patients were included. Median follow-up was 7.2 years. Patients with periodontal diseases had 17% increased risk of cancer compared with the expected counts for the corresponding age and sex groups (SIR: 1.17; 95% CI: 1.04–1.3, P = 0.006). The increased cancer risk was statistically significant in women (SIR: 1.24; 95% CI: 1.05–1.45, P = 0.008) but not in men. Among women with periodontal disease, the risks of breast cancer (SIR: 2.19) and head and neck cancer (SIR: 4.71) were significantly increased. Among men, the risks of prostate cancer (SIR: 1.84), head and neck cancer (SIR: 3.55), and hematological cancers (SIR: 1.76) were significantly increased. This study showed that periodontal diseases were associated with increased risk of several cancers. Besides other well-known benefits for health, the provision of oral/dental health should be considered and employed as a cancer prevention measure.
Background: Periostin is a protein present in alveolar bone and periodontal ligament whose function is related to response to external forces. The aims of this study are to detect levels of periostin in peri‐implant sulcular fluid (PISF) and gingival crevicular fluid (GCF) and to evaluate the relationship between periostin, pyridinoline cross‐linked carboxyterminal telopeptide of Type I collagen (ICTP), and C‐terminal cross‐linked telopeptide of Type I collagen (CTX) levels and clinical inflammatory symptoms and duration of functional loading.Methods: The study population comprised nine women and four men with mean age 43.23 ± 12.48. Twenty “bone‐level designed” dental implants (DIs) placed in molar or premolar sites, without any signs of peri‐implant bone loss and with a restoration in function for at least 12 months, were included in the study with 20 contralateral natural teeth (NT) as controls. Clinical parameters and restoration dates of the implants were recorded. PISF, GCF, ICTP, CTX, and periostin levels were evaluated using enzyme‐linked immunosorbent assay.Results: ICTP, CTX, and periostin levels were similar between DI and NT groups. There were no statistically significant differences between PISF and GCF values. When implants were grouped as healthy (gingival index [GI] = 0) and inflamed (GI ≥0), ICTP levels and PISF volume were lower in healthy implants compared with the inflamed group. Both periostin and CTX levels were negatively correlated with functioning time, suggesting less bone remodeling around DIs at later stages of functioning.Conclusion: Findings of this study suggest collagen breakdown products may be used as markers to evaluate peri‐implant metabolism.
1 January 2026 in Journal of Periodontal & Implant Science
The relation between rheumatology and dentistry has increasing clinical importance, particularly in patients with systemic autoimmune diseases such as rheumatologic disorders and vasculitis. Periodontitis is a chronic inflammatory disease characterized by the progressive destruction of periodontal supporting tissues, occurring from a dysbiotic shift within the oral microbiota. Although the primary etiological factor of periodontal disease is bacterial plaque, the main factor causing breakdown in the periodontium is the host-mediated immunoinflammatory response. Periodontal diseases can have both direct and indirect impacts on overall systemic health through possible remote effects of the inflammatory response caused by bacterial infection of the periodontium, and serving as a risk factor for systemic diseases or conditions affecting general health. Oral lesions may develop in patients with vasculitis during the course of the disease, and oral findings may even be the first clinical findings before the diagnosis. Bone-modifying agents (BMAs) such as bisphosphonates, used to prevent osteoporosis associated with various autoimmune and immune-mediated inflammatory disease, can predispose individuals to complications affecting bone metabolism and oral health, including medication-related osteonecrosis of the jaw (MRONJ). In such cases, effective prevention, early diagnosis and multidisciplinary management are essential to reduce morbidity and maintain oral function. The present review aims to evaluate the potential interactions between periodontitis and rheumatological diseases; to assess the etiological/pathological basis of these diseases and the multidisciplinary approaches between periodontal and rheumatologic disciplines in promoting oral health and reducing the risk of osteonecrosis in patients with vasculitis.